Jeffrey Flash
Foot & Ankle Surgery · Forest Park, GANPI 1255318937
Payments from drug & device makers
What this record shows
This record is dominated by other: $110,400 of the $114,034 with a category attached, or 96.8%. Convatec Inc. accounts for 97.2% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2024 at $111,156 and has fallen 99.4% since, to $694 in 2025. Among foot & ankle surgery clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 128 payments — averaging $890.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Convatec Inc.$111K
- Treace Medical Concepts, Inc.$995
- Averitas Pharma Inc.$587
- Amgen$430
- Triad Life Sciences Inc.$221
- Organogenesis Inc.$182
- plus $807 from 12 others
What the payments were for
- Food & beverage$3,5983%
- Education$360%
- Other$110,40097%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Convatec Inc. | 28 | $110,811 |
| Treace Medical Concepts, Inc. | 30 | $995 |
| Averitas Pharma Inc. | 19 | $587 |
| Amgen | 20 | $430 |
| Triad Life Sciences Inc. | 7 | $221 |
| Organogenesis Inc. | 4 | $182 |
| Bone Support Inc. | 1 | $155 |
| Pacira Pharmaceuticals Incorporated | 1 | $118 |
| Melinta Therapeutics, LLC | 1 | $116 |
| Trilliant Surgical LLC. | 1 | $108 |
| Smith+Nephew | 3 | $69 |
| Kowa Pharmaceuticals America, Inc. | 4 | $56 |
| Zyla Life Sciences, Inc. | 3 | $54 |
| GRT US Holding, Inc. | 2 | $52 |
| DJO, LLC | 1 | $36 |
| Stryker | 1 | $16 |
| Aroa Biosurgery Incorporated | 1 | $16 |
| Paragon 28, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- InnovaMatrix AC$110,813
- RAYOS$693
- CERAMENTBONE VOID FILLER$155
- CERAMENT G$155
- PERCUPLASTY TRAY$149
- Qutenza$121
- EXPAREL$118
- Lapiplasty System$116
- Baxdela$116
- Apligraf$108
- MIB$108
How this compares
$114,034 in reported general payments places this provider in the 95th percentile of 239 foot & ankle surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| QutenzaCapsaicin/Skin Cleanser | 12 | $42,561 |
| Diclofenac Sodium | 13 | $18,247 |
| Gabapentin | 112 | $2,126 |
| Pregabalin | 36 | $521 |
| Triamcinolone Acetonide | 59 | $434 |
| Ketoconazole | 20 | $384 |
| Terbinafine Hcl | 33 | $285 |
| Indomethacin | 16 | $220 |
| Doxycycline Hyclate | 19 | $175 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 29 | $138 |
| Mupirocin | 17 | $125 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $93 |
| Meloxicam | 14 | $43 |
| Tramadol Hcl | 12 | $40 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GRT US Holding, Inc.Qutenza | $52 | $42,56112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 239 foot & ankle surgery providers in Georgia.
Other foot & ankle surgery in Forest Park
- Robert WeinsteinFayetteville$394K
- Jason BariteauAtlanta$199K
- Scott RomanPeachtree City$118K
- Mickey StappThomson$110K
- David MurphyWaycross$55K
- Rishin KadakiaAtlanta$53K
- Javan BassLithonia$43K
- Bhavin MehtaAtlanta$43K
- Corbett ThigpenAugusta$41K
- Eric MassaTifton$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.